Last updated on February 2019
A Study of Olaratumab (LY3012207) Doxorubicin and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Brief description of study
The purpose of this study is to evaluate the safety of ifosfamide when added to the combination regimen of olaratumab and doxorubicin in participants with advanced or metastatic soft tissue sarcoma (STS).
Clinical Study Identifier: NCT03283696
Start Over
Peter Reichardt
HELIOS Klinikum Berlin-Buch Berlin, Germany5.34miles